RecallRadar

FDA Device recall Z-0238-2022

Philips Azurion systems with software releases 2.1(L1) and 2.1(L2)

On 2021-12-01 the FDA classified a Class II recall of Philips Azurion systems with software releases 2.1(L1) and 2.1(L2) by Philips Healthcare, citing 3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product extends the functionality of compatible X-ray equipment with the capabilit….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0238-2022
ClassificationClass II
Statusongoing
Initiated2021-09-24
Published2021-12-01
Last updated2026-09-13 11:56 UTC
CompanyPhilips Healthcare
DistributionUS

Product

Philips Azurion systems with software releases 2.1(L1) and 2.1(L2)

Reason

3D-RA is a reconstruction software product that can be used with the Philips Azurin system. This product extends the functionality of compatible X-ray equipment with the capability of 3D X-ray imaging. Before starting a 3D-RA scan, the detector of the Philips Azurion system must be positioned in portrait or landscape orientation with an angle of 0 or +/-90 degrees relative to the 3D scan direction. Philips has discovered that Azurion releases 2.1(L1) and 2.1(L2) allow creation of a 3D-RA scan with a deviating detector orientation of up to 3 degrees from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees), relative to the 3D scan direction. 3D-RA scans with a deviating detector orientation of ore than 1.0 degree from the exact portrait or landscape orientation (i.e., at 0 or +/-90 degrees) cannot be reconstructed with the 3D-RA reconstruction software.

Identifiers

code_infoAzurion 2.1(L1) and 2.1(L2)

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0238-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.